# Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia

> **NCT00664274** · NA · UNKNOWN · sponsor: **Manhattan Psychiatric Center** · enrollment: 142 (estimated)

## Conditions studied

- Chronic Schizophrenia

## Interventions

- **BEHAVIORAL:** Cognitive remediation therapy
- **GENETIC:** COMT Genotyping

## Key facts

- **NCT ID:** NCT00664274
- **Lead sponsor:** Manhattan Psychiatric Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2015-01
- **Final completion:** 2016-10
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2015-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664274, "Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00664274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*